5, 10-Dihydroimidazo[2,1-b]quinazolines and pharmaceutical compositions
申请人:Sandoz Ltd.
公开号:US04372956A1
公开(公告)日:1983-02-08
A 5,10-dihydroimidazo[2,1-b]quinazoline in which at least one ring carbon atom, other than the carbon atom in the 2-position, bears a substituent, or a pharmaceutically acceptable acid addition salt thereof is a useful cardiotonic agent and vasodilator in heart insufficiency and a blood platelet aggregation inhibitor.